Divisions, centres, and units in Life Sciences

Improving our understanding of pathogen biology and transforming drug discovery for both infectious and non-infectious diseases; making the previously undruggable, druggable.

Our research is concerned with the pathologies associated with cancer, diabetes, infectious disease, autoimmunity and allergy.

We are bolstering the University of Dundee’s world-leading position in a field that is revolutionising drug discovery.

We bring together scientists with skills in developing and applying computational, mathematical and biophysical techniques to questions in biological and medical research.

We translate basic science into lead compounds to validate putative drug targets, to use as tools to investigate disease pathways and, when appropriate, advance to pre-clinical drug candidates.

We study molecular mechanisms that preserve genome integrity, support cell proliferation, trigger senescence and maintain cell identity. Defects in such mechanisms lead to a range of human diseases and are central to the development, evolution and treatment of human cancer.

We focus on the understanding of the biological roles of phosphorylation and ubiquitylation and how disruption of these processes cause human diseases such as neurodegeneration, cancer, hypertension and immune disorders.

We investigate the molecular mechanisms that underpin cell and tissue biology. This includes the regulation of cell division and how the expression and function of genes and proteins are regulated during differentiation in embryonic and adult tissues.

Our research flows from fundamental science using model organisms to translational research on medically- and economically-significant pathogens

Our partnership brings together our discovery-based molecular plant science investigating fundamental questions of plant biology, with scientists with knowledge of applied research in crop species including front-line crop and pathogen genomics, genetics and cultivar production.

Our centre brings together the Drug Discovery Unit, the Mode of Action group and the Parasitology research groups providing an integrated pathway from discovery science to pre-clinical candidate selection.